We acted as the exclusive financial advisor and book running underwriter to BioPharmX Corp. in its initial public offering and subsequent financings. The transaction included participation from existing investors, including investment vehicles of Franklin Advisors. BioPharmX is a Silicon Valley-based specialty pharmaceutical company focusing on dermatology and women’s health. The firm seeks to provide products through proprietary platform technologies for prescription, over-the-counter, and supplement applications in the health and wellness markets. BioPharmX intends to use the net proceeds of the offering for general corporate purposes, which may include funding research and development, increasing working capital, and acquisitions or investments in businesses, products,or technologies that are complementary to its own.

Note: This work was performed prior to joining Stout.